期刊文献+

Enzalutamide Associated with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Overlap: A Case Report

Enzalutamide Associated with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Overlap: A Case Report
下载PDF
导出
摘要 <span style="font-family:Verdana;">Enzalutamide is a hormonal therapy that blocks the action of androgens, such as testosterone in the treatment of metastatic castration-resistant prostate cancer. </span><span style="font-family:Verdana;">Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) overlap and are part of an adverse drug reaction continuum of disease, in which there is a 10% - 30% involvement of the skin surface with mucositis, blisters, skin slough, and a macular rash. A 66-year-old male was treated with enzalutamide for metastatic prostate cancer and developed SJS/TEN overlap with 25% total body surface area skin involvement. The patient received a </span><span style="font-family:Verdana;">seven-day course of cyclosporine to which he responded by re-epithelialization </span><span style="font-family:Verdana;">but succumbed to multi-organ failure. While SJS/TEN has been reported with apalutamide, to our knowledge, this is the first case of SJS/TEN overlap with enzalutamide.</span> <span style="font-family:Verdana;">Enzalutamide is a hormonal therapy that blocks the action of androgens, such as testosterone in the treatment of metastatic castration-resistant prostate cancer. </span><span style="font-family:Verdana;">Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) overlap and are part of an adverse drug reaction continuum of disease, in which there is a 10% - 30% involvement of the skin surface with mucositis, blisters, skin slough, and a macular rash. A 66-year-old male was treated with enzalutamide for metastatic prostate cancer and developed SJS/TEN overlap with 25% total body surface area skin involvement. The patient received a </span><span style="font-family:Verdana;">seven-day course of cyclosporine to which he responded by re-epithelialization </span><span style="font-family:Verdana;">but succumbed to multi-organ failure. While SJS/TEN has been reported with apalutamide, to our knowledge, this is the first case of SJS/TEN overlap with enzalutamide.</span>
作者 Sharjeel Israr Christopher R. Mellon Haley J. Springs Asia N. Quan Marc R. Matthews Sharjeel Israr;Christopher R. Mellon;Haley J. Springs;Asia N. Quan;Marc R. Matthews(Department of General Surgery, Creighton University School of Medicine, Phoenix Campus, St. Joseph Hospital and Medical Center, Phoenix, AZ, USA;Honor Health Medical Center, Department of Surgery, Scottsdale, AZ, USA;Department of General Surgery, Honor Health John C. Lincoln Medical Center, Phoenix, AZ, USA;Department of Pharmacy, Valleywise Health Medical Center, Phoenix, AZ, USA;The Arizona Burn Center, Phoenix, AZ, USA)
出处 《Surgical Science》 2021年第12期421-426,共6页 外科学(英文)
关键词 Prostate Cancer Enzalutamide Stevens-Johnson Syndrome Toxic Epidermal Necrolysis SJS/TEN Prostate Cancer Enzalutamide Stevens-Johnson Syndrome Toxic Epidermal Necrolysis SJS/TEN
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部